3,4-dihydroxyphenylethanol has been researched along with Infections, Coronavirus in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Beccari, T; Bertelli, M; Capodicasa, N; Ceccarini, MR; Codini, M; Dundar, M; Ergoren, MC; Farronato, G; Farronato, M; Kroni, D; Manara, E; Paolacci, S; Percio, M; Sanlidag, T; Tartaglia, GM; Tezzele, S | 1 |
Anpilogov, K; Bertelli, M; Camilleri, G; Dautaj, A; Dhuli, K; Dundar, M; Ergoren, MC; Farronato, G; Farronato, M; Gunsel, IS; Manara, E; Paolacci, S; Sanlidag, T; Sayan, M; Suer, HK; Sultanoglu, N; Tartaglia, GM; Tuncel, G | 1 |
2 other study(ies) available for 3,4-dihydroxyphenylethanol and Infections, Coronavirus
Article | Year |
---|---|
Pilot study for the evaluation of safety profile of a potential inhibitor of SARS-CoV-2 endocytosis.
Topics: Adult; Aged; Aged, 80 and over; alpha-Cyclodextrins; Antiviral Agents; Betacoronavirus; Caco-2 Cells; Cell Culture Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Endocytosis; Female; Humans; Male; Middle Aged; Oral Sprays; Pandemics; Phenylethyl Alcohol; Pilot Projects; Pneumonia, Viral; SARS-CoV-2; Young Adult | 2020 |
A pilot study on the preventative potential of alpha-cyclodextrin and hydroxytyrosol against SARS-CoV-2 transmission.
Topics: Adult; alpha-Cyclodextrins; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cyprus; Endocytosis; Female; Humans; Male; Middle Aged; Oral Sprays; Pandemics; Phenylethyl Alcohol; Pilot Projects; Pneumonia, Viral; SARS-CoV-2; Viral Load | 2020 |